CYP4F2 genetic polymorphisms are associated with coronary heart disease in a Chinese population

被引：0
|
作者：
Yu, Changqing [1 ]
Yan, Qingkai [1 ]
Wang, Xukai [1 ]
机构：
[1] Third Mil Med Univ, Daping Hosp, Dept Cardiol, Chongqing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 66卷 / 16期
关键词：
D O I：
10.1016/j.jacc.2015.06.323
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
GW26-e1832
引用
下载
收藏
页码：C81 / C81
页数：1
相关论文
共 50 条
  • [41] CYP4F2 polymorphism and bleeding complications in Chinese patients on warfarin therapy
    Liu, Jia
    Yin, Tong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C131 - C132
  • [42] CYP4F2 gene V433M polymorphism is associated with ischemic stroke in the male Northern Chinese Han population
    Deng, Shumin
    Zhu, Gang
    Liu, Fang
    Zhang, Hui
    Qin, Xue
    Li, Lei
    He Zhiyi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (04): : 664 - 668
  • [43] Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population
    Giri, Anil K.
    Khan, Nazir M.
    Grover, Sandeep
    Kaur, Ismeet
    Basu, Analabha
    Tandon, Nikhil
    Scaria, Vinod
    Kukreti, Ritushree
    Brahmachari, Samir K.
    Bharadwaj, Dwaipayan
    PHARMACOGENOMICS, 2014, 15 (10) : 1337 - 1354
  • [44] Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients
    Zhuang, Wenfang
    Wen, Wei
    Xuan, Binbin
    Chen, Yanhong
    Cao, Yanan
    Sun, Zhixin
    Ma, Jun
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (02) : 167 - 174
  • [45] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Farajzadeh-Dehkordi, Mahvash
    Samiee-Rad, Fatemeh
    Farzam, Seyed Saeed
    Javadi, Amir
    Cheraghi, Sara
    Hamedi-Asl, Dariush
    Rahmani, Babak
    PHARMACOLOGICAL REPORTS, 2023, 75 (03) : 695 - 704
  • [46] Replication study of CYP4F2 association with warfarin response in an Israeli population
    不详
    PHARMACOGENOMICS, 2012, 13 (08) : 863 - 864
  • [47] Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension
    Ongun, Mert C.
    Tonyali, Nazan Vanli
    Kaplan, Ozan
    Deger, Ilter
    Celebier, Mustafa
    Akduman, Nursabah E. Basci
    Sahin, Dilek
    Yucel, Aykan
    Babaoglu, Melih O.
    PLACENTA, 2023, 137 : 88 - 95
  • [48] CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy
    Wang, Hong-Juan
    Ma, Cong
    Yang, Jie
    Xu, Qiang
    Zhang, Yan
    Gao, Lei
    Xu, Bin
    Zhang, Yu-Xiao
    Li, Yang
    Yin, Tong
    JOURNAL OF GERIATRIC CARDIOLOGY, 2012, 9 (02) : 209 - 210
  • [49] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Mahvash Farajzadeh-Dehkordi
    Fatemeh Samiee-Rad
    Seyed Saeed Farzam
    Amir Javadi
    Sara Cheraghi
    Dariush Hamedi-Asl
    Babak Rahmani
    Pharmacological Reports, 2023, 75 : 695 - 704
  • [50] Warfarin Pharmacogenetics: Polymorphisms of the CYP2C9, CYP4F2, and VKORC1 Loci in a Genetically Admixed Omani Population
    Pathare, Anil V.
    Al Zadjali, Shoaib
    Misquith, Rhea
    Alkindi, Salam S.
    Panjwani, Vinodh
    Lapoumeroulie, Claudine
    Pravin, Sahaya
    Paldi, Andras
    Krishnamoorthy, Rajagopal
    HUMAN BIOLOGY, 2012, 84 (01) : 67 - 77
12345